oxazoles has been researched along with Astrocytoma, Grade IV in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Appelt-Menzel, A; Cubukova, A; Gohla, A; Haider, MS; Jeanclos, E; Kataoka, K; Kinoh, H; Krafft, M; Lübtow, MM; Luxenhofer, R; Meier, L; Oerter, S; Quader, S; Rist, M; Sampetrean, O; Schulte, C | 1 |
Chen, Y; Cheng, YC; Hsieh, CH; Hueng, DY; Tsai, WC | 1 |
Ali, MA; Chattopadhyay, A; Ding, LH; Habib, AA; Reis, A; Saha, D; Story, MD | 1 |
Ali, MA; Choy, H; Habib, AA; Saha, D | 1 |
4 other study(ies) available for oxazoles and Astrocytoma, Grade IV
Article | Year |
---|---|
Topics: Antineoplastic Agents; Atorvastatin; Blood-Brain Barrier; Cell Line, Tumor; Cell Movement; Cell Survival; Chromatography, High Pressure Liquid; Drug Compounding; Dynamic Light Scattering; Glioblastoma; Humans; Induced Pluripotent Stem Cells; Micelles; Nanomedicine; Neoplastic Stem Cells; Oxazoles | 2020 |
Cordycepin inhibits migration of human glioblastoma cells by affecting lysosomal degradation and protein phosphatase activation.
Topics: Ammonium Chloride; Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Deoxyadenosines; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Lysosomes; Marine Toxins; Mice, Nude; Neoplasm Proteins; Okadaic Acid; Oxazoles; Phosphoprotein Phosphatases; Proteolysis; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
SNS-032 prevents hypoxia-mediated glioblastoma cell invasion by inhibiting hypoxia inducible factor-1alpha expression.
Topics: Antineoplastic Agents; Cell Line, Tumor; Collagen; Cyclooxygenase 2 Inhibitors; DNA Primers; Drug Combinations; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Laminin; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Oxazoles; Proteoglycans; RNA, Small Interfering; Thiazoles; Vascular Endothelial Growth Factor A | 2009 |
SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor.
Topics: Angiogenesis Inhibitors; Cell Movement; Cell Proliferation; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Endothelial Cells; Glioblastoma; Humans; Neovascularization, Pathologic; Oxazoles; Protein Kinase Inhibitors; Thiazoles; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2007 |